Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence

Pancreatic ductal adenocarcinoma (PDAC) is an extraordinarily lethal disease, which, despite a more or less efficient chemotherapeutic treatment, systematically displays a rapid and uncontrolled progression towards a fatal recurrence. Determining which cells give rise to such tumor recurrence is thu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoscience
Autors principals: Molejon, Maria Inés, Tellechea, Juan Ignacio, Moutardier, Vincent, Gasmi, Mohamed, Ouaissi, Mehdi, Turrini, Olivier, Delpero, Jean-Robert, Dusetti, Nelson, Iovanna, Juan
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2015
Matèries:
Research Perspective
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4506359/
https://ncbi.nlm.nih.gov/pubmed/26244163
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars